2024
Effectiveness of dolutegravir-based regimens compared to raltegravir-, elvitegravir-, bictegravir, and darunavir-based regimens among older adults with HIV in the Veterans Aging Cohort Study (VACS)
Yan L, Henegar C, Marconi V, Gordon K, Hicks C, Vannappagari V, Justice A, Aslan M. Effectiveness of dolutegravir-based regimens compared to raltegravir-, elvitegravir-, bictegravir, and darunavir-based regimens among older adults with HIV in the Veterans Aging Cohort Study (VACS). AIDS Research And Therapy 2024, 21: 96. PMID: 39709467, PMCID: PMC11662819, DOI: 10.1186/s12981-024-00681-w.Peer-Reviewed Original ResearchMeSH KeywordsAgedAmidesAnti-HIV AgentsCohort StudiesDarunavirDrug Therapy, CombinationFemaleHeterocyclic Compounds, 3-RingHeterocyclic Compounds, 4 or More RingsHIV InfectionsHIV Integrase InhibitorsHumansMaleMiddle AgedOxazinesPiperazinesPyridazinesPyridonesQuinolonesRaltegravir PotassiumTreatment OutcomeVeteransViral LoadConceptsVeterans Aging Cohort StudyRAL-based regimenAntiretroviral therapyAging Cohort StudyCohort studyOdds of virologic suppressionIntegrase strand transfer inhibitorsDarunavir-based regimensDolutegravir-based regimensDTG-based regimensAntiretroviral therapy experienceHuman immunodeficiency virusDTG-based regimenInverse probability of treatment weightingStrand transfer inhibitorsBackgroundReal-world dataProbability of treatment weightingMethodsThis cohort studyVirologic suppressionVirological failureVirological effectImmunodeficiency virusDarunavir/ritonavirClinical outcomesRegimen initiation
2012
Patient-Reported Symptoms on the Antiretroviral Regimen Efavirenz/Emtricitabine/Tenofovir
Edelman EJ, Gordon K, Rodriguez-Barradas MC, Justice F. Patient-Reported Symptoms on the Antiretroviral Regimen Efavirenz/Emtricitabine/Tenofovir. AIDS Patient Care And STDs 2012, 26: 312-319. PMID: 22612469, PMCID: PMC3412583, DOI: 10.1089/apc.2012.0044.Peer-Reviewed Original ResearchMeSH KeywordsAdenineAlkynesAnti-HIV AgentsBenzoxazinesCohort StudiesCross-Sectional StudiesCyclopropanesDeoxycytidineDrug Therapy, CombinationEmtricitabineFemaleHealth StatusHIV InfectionsHumansMaleMiddle AgedOrganophosphonatesQuality of LifeSeverity of Illness IndexTenofovirTreatment OutcomeVeteransConceptsEFV/FTC/TDFCombination antiretroviral therapyFTC/TDFHealth-related qualityTDF useSymptom experienceEfavirenz/emtricitabine/tenofovirVeterans Aging Cohort StudyPatient-reported symptomsAging Cohort StudyEmtricitabine/tenofovirCross-sectional analysisAntiretroviral therapyCohort studyMost patientsPatient tolerabilitySymptom burdenTreatment characteristicsPatientsDisease severityAnalytic sampleTenofovirSymptomsTDFAssociation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply